Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Tornier has entered into exclusive world-wide technology collaboration in the field of orthopedic soft tissue repair with BioSurface Engineering Technologies to develop, commercialize, and distribute products that will incorporate BioSET's synthetic growth factor technology.
Subscribe to our email newsletter
The collaboration will focus initially on ligament and tendon repair products that will feature coatings based on BioSET’s proprietary F2A synthetic growth factor technology. The BioSET F2A peptide is a synthetic mimetic of the natural human FGF-2 growth factor that is known to play key role in the body’s healing and repair processes.
Doug Kohrs, president and CEO of Tornier, said: “Our collaboration with BioSET evidences Tornier’s long term commitment to innovative biologic and synthetic materials to improve clinical outcomes for both hard tissue and soft tissue orthopedic repair procedures.”